Back

Interventions which reduce risk of cardiovascular disease in women after preeclampsia: a systematic review

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pregnancy and cardiovascular disease prevention Pregnancy and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jessica Victoria Yao

Royal Melbourne Hospital, Melbourne (Australia)

6 More presentations in this session

Presentation thumbnail
Risk of arrhythmias in women with mitral valve prolapse during pregnancy and puerperium
Doctor S. Gefen (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Sociodemographic, cardiovascular and pregnancy associated risk factors to develop peri-partum cardiomyopathy
Doctor H. Shmueli (Beer Sheva, IL)
Abstract Slides Video
Presentation thumbnail
Quantification of the biological stresses induced by healthy pregnancies using artificial intelligence interpretation of electrocardiograms
Professor R. Carter (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
Peripartum cardiomyopathy: an often mislabelled diagnosis
Miss A. Taniskidi (London, GB)
Abstract Slides Video
Presentation thumbnail
Proteomic profiling identifies novel biomarkers and mechanistic pathways in mental stress-induced myocardial ischemia
Doctor B. Bai (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Pregnancy and cardiovascular disease prevention

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Subclinical atherosclerosis in women who have had preeclampsia: a systematic review and meta analysis
thumbnail
Congress Presentation
Evaluation of the age-related prevalence of cardiovascular risk factors to guide systematic long-term follow-up after preeclampsia
thumbnail
Congress Presentation
Maternal myocardial recovery twelve months post-partum in women with pregnancies complicated by gestational diabetes or preeclampsia - single center, longitudinal cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources